Your Location:
Home >
Browse articles >
Shashen Maidong Tang Enhances Efficacy of Chemotherapy in Mouse Model of Lewis Lung Cancer by Modulating JAK2/STAT3 Signaling Pathway
Updated:2026-02-28
Previous|Next
    • Shashen Maidong Tang Enhances Efficacy of Chemotherapy in Mouse Model of Lewis Lung Cancer by Modulating JAK2/STAT3 Signaling Pathway

      Enhanced Publication
    • “Experts used network pharmacology and animal experiments to verify the synergistic mechanism of Sha Shen Mai Dong Tang on lung cancer chemotherapy, and found that it may work by regulating the JAK2/STAT3 signaling pathway, providing new ideas for lung cancer treatment.”
    • YU Lin , WANG Yaoyao , LIU Limin , HU Zuowei , ZHOU Yanping , WANG Shang
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 5, Pages: 1-10(2026)
    • DOI: 10.13422/j.cnki.syfjx.20251023     

      CLC:
    • Revised:2025-02-24 ,

      Accepted:14 March 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 4 ) Tabs( 6 )

  • References

  • Publication Info

  • Metrics

310

Views

212

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Investigating Therapeutic Effect and Mechanism of Zhengqi Prescription on Cancer-related Fatigue by UPLC-MS and Network Pharmacology
Mechanism of Huangqi Xiayuxue Decoction Against Hepatocellular Carcinoma via PI3K/Akt/FoxO Signaling Pathway
Material Basis of Entada phaseoloides Against Neuropathic Pain Based on in vitro Chemical Profiling and in vivo Absorbed Constituents
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway

Related Author

YU Jianghan
ZHAO Yiying
CHENG Mingsai
LU Yi
ZHOU Bingxia
WU Mingxia
WANG Ziying
CAO Liang

Related Institution

Jiangsu Kanion Pharmaceutical Co. Ltd./ State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine
Shanghai Tufeng Pharmaceutical Technology Company Limited
School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine